Filing Details
- Accession Number:
- 0000874716-24-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-09 17:01:55
- Reporting Period:
- 2024-02-07
- Accepted Time:
- 2024-02-09 17:01:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219445 | P Brian Mckeon | One Idexx Drive Westbrook ME 04092 | Evp, Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-07 | 23,326 | $141.60 | 53,044 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-02-07 | 615 | $563.82 | 52,429 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 1,581 | $564.98 | 50,848 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 701 | $566.53 | 50,147 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 1,564 | $567.35 | 48,583 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 1,469 | $568.84 | 47,114 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 3,912 | $569.91 | 43,202 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 5,675 | $570.97 | 37,527 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 7,128 | $571.84 | 30,399 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-07 | 681 | $572.80 | 29,718 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2024-02-07 | 23,326 | $0.00 | 23,326 | $141.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 18,050 | Indirect | by Estony McKeon Family, LLC |
Footnotes
- Includes a total of 25.247 shares purchased under the Issuer Employee Stock Purchase Plan on September 29, 2023 and December 29, 2023.
- Represents the weighted average price of the shares sold ranging from a low of $563.48 to a high of $564.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $564.63 to a high of $565.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $565.89 to a high of $566.84 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $566.92 to a high of $567.86 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $568.33 to a high of $569.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $569.34 to a high of $570.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $570.345 to a high of $571.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $571.36 to a high of $572.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $572.42 to a high of $573.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
- Not applicable.